Opportunity Information: Apply for RFA DA 09 008

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Brain Imaging Studies of Negative Reinforcement in Humans (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
  • This funding opportunity was created on Nov 5, 2008 and posted on Nov 5, 2008.
  • Applicants must submit their applications by Feb 19, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $250,000.00 in funding.
  • Eligible applicants include: Native American tribal governments (Federally recognized) For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education City or township governments County governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments Public housing authorities/Indian housing authorities.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for RFA DA 09 008

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Brain Imaging Studies of Negative Reinforcement in Humans (R01) funding opportunity (RFA-DA-09-008) is a research grant announcement from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH). It calls for hypothesis-driven R01 projects that use human brain imaging and related neuroscience approaches to explain how aversive events shape behavior through negative reinforcement, also described here as avoidance learning. The central idea is that, while the neuroscience of reward and positive reinforcement has been studied extensively, the brain mechanisms that support avoiding or escaping unpleasant outcomes are less understood, even though preclinical research suggests these processes can play a major role in substance use and addiction.

The announcement defines negative reinforcement and avoidance learning as essentially the same concept for the purposes of this program: behaviors and cognitive strategies that are learned and sustained because they reduce, prevent, or remove aversive events. Importantly, the FOA treats aversive events broadly. They can be external, such as threatening or stressful environmental cues, or internal, such as uncomfortable emotional or physiological states. In a substance use context, these internal aversive states might include anxiety, dysphoria, stress responses, or withdrawal-related discomfort that can motivate drug taking as a form of escape or relief. Applicants are expected to propose studies that directly test mechanistic hypotheses about the brain regions, circuits, and processes that support avoidance learning in humans, rather than purely descriptive imaging work.

Projects may involve healthy participants, people currently using substances, individuals in abstinence or recovery, or people at elevated risk for substance abuse. Regardless of the sample, every application must clearly explain how the work will advance understanding of substance abuse, consistent with NIDA's mission. In practice, that means proposals should connect avoidance-related neural mechanisms to clinically meaningful addiction questions such as vulnerability, escalation and maintenance of use, relapse risk, craving driven by stress or negative affect, or why some individuals rely on substances to manage aversive internal states.

Administratively, this is a discretionary grant opportunity using the NIH Research Project Grant (R01) mechanism. The program falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs). The estimated total funding level listed is $3,000,000, with an award ceiling of $250,000 (as provided in the announcement summary). Cost sharing or matching is not required. The opportunity was posted on November 5, 2008, with an original and current closing date of February 19, 2009, and it was archived March 22, 2009.

Eligibility is broad and includes public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (other than small businesses are explicitly listed, and small businesses are also included), and multiple levels of government entities (state, county, city/township, special district, and eligible tribal governments and organizations). The FOA also notes additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), tribally controlled colleges and universities (TCCUs), U.S. territories or possessions, regional organizations, and non-U.S. entities (foreign organizations), among others.

Overall, the opportunity is aimed at building a stronger clinical neuroscience foundation for negative reinforcement processes in humans, with the explicit expectation that this knowledge will clarify key mechanisms that contribute to substance abuse and addiction and, by extension, inform prevention and treatment strategies that address avoidance-driven behavior.

Frequently Asked Questions (FAQs)

1) What is the name of this funding opportunity?

The opportunity is titled Brain Imaging Studies of Negative Reinforcement in Humans (R01) and is identified as RFA-DA-09-008.

2) Which agency is offering this grant?

This is a research grant announcement from the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH).

3) What grant mechanism does this opportunity use?

The funding opportunity uses the NIH Research Project Grant (R01) mechanism and is described as a discretionary grant opportunity.

4) What is the main scientific focus of this FOA?

It calls for hypothesis-driven R01 projects that use human brain imaging and related neuroscience approaches to explain how aversive events shape behavior through negative reinforcement, also described in this program as avoidance learning.

5) How does the FOA define "negative reinforcement" for the purposes of this program?

For this program, negative reinforcement and avoidance learning are treated as essentially the same concept: behaviors and cognitive strategies learned and sustained because they reduce, prevent, or remove aversive events.

6) What counts as an "aversive event" in this announcement?

The FOA treats aversive events broadly. They may be:

  • External, such as threatening or stressful environmental cues, or
  • Internal, such as uncomfortable emotional or physiological states.

7) How does this topic connect to substance use and addiction?

In a substance use context, internal aversive states can include anxiety, dysphoria, stress responses, or withdrawal-related discomfort. These states can motivate drug taking as a form of escape or relief. The FOA emphasizes that avoidance-related processes may play a major role in substance use and addiction.

8) What kind of studies is NIDA looking for?

NIDA is looking for studies that directly test mechanistic hypotheses about the brain regions, circuits, and processes supporting avoidance learning in humans. The announcement explicitly distinguishes this from purely descriptive imaging projects.

9) Are purely descriptive imaging studies responsive to this FOA?

Based on the announcement description, applications are expected to go beyond description and directly test mechanistic hypotheses. Projects that are only descriptive are not aligned with that expectation.

10) Who can be studied as participants in proposed projects?

Projects may involve:

  • Healthy participants
  • People currently using substances
  • Individuals in abstinence or recovery
  • People at elevated risk for substance abuse

11) Do projects using healthy participants need to address substance abuse relevance?

Yes. Regardless of the sample, every application must clearly explain how the work will advance understanding of substance abuse, consistent with NIDA's mission.

12) What kinds of addiction-related questions should the application connect to?

The FOA indicates proposals should connect avoidance-related neural mechanisms to clinically meaningful addiction questions such as:

  • Vulnerability to substance abuse
  • Escalation and maintenance of use
  • Relapse risk
  • Craving driven by stress or negative affect
  • Why some individuals rely on substances to manage aversive internal states

13) Why is NIDA emphasizing negative reinforcement in this program?

The announcement notes that while the neuroscience of reward and positive reinforcement has been studied extensively, the brain mechanisms that support avoiding or escaping unpleasant outcomes are less understood, even though preclinical research suggests they can be important in substance use and addiction.

14) What is the CFDA number for this program?

The program is listed under CFDA 93.279 (Drug Abuse and Addiction Research Programs).

15) What is the estimated total funding level?

The estimated total funding level listed in the announcement is $3,000,000.

16) What is the award ceiling?

The award ceiling is listed as $250,000 (as provided in the announcement summary).

17) Is cost sharing or matching required?

No. The opportunity states that cost sharing or matching is not required.

18) When was this opportunity posted?

The opportunity was posted on November 5, 2008.

19) What was the closing date for applications?

The original and current closing date listed is February 19, 2009.

20) What does it mean that the opportunity is archived?

The listing indicates it was archived on March 22, 2009, meaning it is presented as a past/closed opportunity in the information provided.

21) What types of organizations are eligible to apply?

Eligibility is broad and includes:

  • Public and private institutions of higher education
  • Nonprofit organizations (including those with and without 501(c)(3) status)
  • For-profit organizations (including small businesses, which are also included)
  • Government entities (state, county, city/township, special district)
  • Eligible tribal governments and organizations

22) Are specialized institution types explicitly noted as eligible?

Yes. The FOA notes additional eligible applicants such as:

  • Alaska Native and Native Hawaiian Serving Institutions
  • Faith-based or community-based organizations
  • Hispanic-serving institutions
  • Historically Black Colleges and Universities (HBCUs)
  • Tribally Controlled Colleges and Universities (TCCUs)
  • U.S. territories or possessions
  • Regional organizations
  • Non-U.S. entities (foreign organizations)

23) Are non-U.S. (foreign) organizations eligible to apply?

Yes. The eligibility list includes non-U.S. entities (foreign organizations).

24) What is the overall goal of the program?

The opportunity aims to build a stronger clinical neuroscience foundation for negative reinforcement processes in humans, with the expectation that this knowledge will clarify mechanisms contributing to substance abuse and addiction and help inform prevention and treatment strategies that address avoidance-driven behavior.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Brain Imaging Studies of Negative Reinforcement in Humans (R21)

Previous opportunity: Fiscal Year 2009 Buffer Zone Protection Program (BZPP)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 09 008

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 09 008) also looked into and applied for these:

Funding Opportunity
Brain Imaging Studies of Negative Reinforcement in Humans (R21) Apply for RFA DA 09 009

Funding Number: RFA DA 09 009
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Instrument Development for Biomedical Applications (R21) Apply for RFA RR 09 001

Funding Number: RFA RR 09 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $125,000
Erythropoiesis Stimulating Agents and Tumor Progression (R01) Apply for PA 09 023

Funding Number: PA 09 023
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Erythropoiesis Stimulating Agents and Tumor Progression (R21) Apply for PA 09 024

Funding Number: PA 09 024
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
National Cancer Institute Program Project (P01) Applications Apply for PAR 09 025

Funding Number: PAR 09 025
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) Apply for PAR 09 026

Funding Number: PAR 09 026
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Education Programs of Excellence in Scientifically Validated Behavioral Treatment (R25) Apply for RFA MH 09 110

Funding Number: RFA MH 09 110
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Shared Instrumentation Grant Program (S10) Apply for PAR 09 028

Funding Number: PAR 09 028
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Mutant Mouse Regional Resource Centers (Limited Competition U42) Apply for RFA RR 09 003

Funding Number: RFA RR 09 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Mutant Mouse Regional Resource Centers (U42) Apply for RFA RR 09 002

Funding Number: RFA RR 09 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $750,000
STUDIES OF ENERGY BALANCE AND CANCER IN HUMANS Apply for PA 04 124

Funding Number: PA 04 124
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fellows (F31) in Nursing Research Apply for PAR 05 091

Funding Number: PAR 05 091
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
IDeA Networks of Biomedical Research Excellence (INBRE) P20 Apply for PAR 08 150

Funding Number: PAR 08 150
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) Apply for PAR 08 225

Funding Number: PAR 08 225
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Specialized Programs of Research Excellence (SPOREs) in Human Cancer for the Year 2008 and 2009 (P50) Apply for PAR 08 020

Funding Number: PAR 08 020
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
National Cooperative Drug Discovery and Development Groups (NCDDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01/U19) Apply for PAR 08 238

Funding Number: PAR 08 238
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01) Apply for PAR 08 245

Funding Number: PAR 08 245
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Biomedical Technology Research Resource (P41) Apply for PAR 08 259

Funding Number: PAR 08 259
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Diversity promoting Institutions Drug Abuse Research Program (DIDARP) (R24) Apply for PAR 09 011

Funding Number: PAR 09 011
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium (Limited Competition) U01 Apply for RFA CA 09 503

Funding Number: RFA CA 09 503
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 09 008", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.